EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV

Adriana Navas iD, Vasiliki Matzaraki, Louise E van Eekeren, Marc J T Blaauw, Albert L Groenendijk, Wilhelm A J W Vos, Maartje Jacobs-Cleophas, Jéssica C Dos Santos, André J A M van der Ven, Leo A B Joosten, Mihai G Netea

Aging Cell · 2025

DOI: 10.1111/acel.14468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Adriana Navas und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Radboud Center of Infectious Diseases, Radboudumc, Radboud University, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: HIV Infections, Proteomics, Aging, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ViiV Healthcare, AIDS-Fonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to the increased burden of non‐AIDS‐related comorbidities in people living with HIV (PLHIV), identifying biomarkers and mechanisms underlying premature aging and the risk of developing age‐related comorbidities is a priority. Evidence suggests that the plasma proteome is an accurate source for measuring biological age and predicting age‐related clinical outcomes. To investigate whether PLHIV on antiretroviral therapy (ART) exhibit a premature aging phenotype, we profiled the plasma proteome of two independent cohorts of virally suppressed PLHIV (200HIV and 2000HIV) and one cohort of people without HIV (200FG) using O‐link technology. Next, we built a biological age‐prediction model and correlated age advancement (the deviation of the predicted age from the chronological age) with HIV‐related factors, comorbidities, and cytokines secreted by immune cells. We identified a common signature of 77 proteins associated with chronological age across all cohorts, most of which were involved in inflammatory and senescence‐related processes. PLHIV showed increased age advancement compared to people without HIV. In addition, age advancement in the 2000HIV cohort was positively associated with prior hepatitis C and cytomegalovirus (CMV) infections, non‐AIDS‐related comorbidities, ART duration, cumulative exposure to the protease inhibitor Ritonavir, as well as higher production of monocyte‐derived proinflammatory cytokines and chemokines and lower secretion of T‐cell derived cytokines. Our proteome‐based predictive model is a promising approach for calculating the age advancement in PLHIV. This will potentially allow for further characterization of the pathophysiological mechanisms linked to accelerated aging and enable monitoring the effectiveness of novel therapies aimed at reducing age‐related diseases in PLHIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsProteomicsAgingProteomeHumansMaleFemaleMiddle AgedAdultBiomarkers

Stichwörter der Autor:innen

HIVO‐linknon‐AIDS‐related comorbiditiespremature agingproteomicssenescence

Substanzen

ProteomeBiomarkers

Autor:innen und Institutionen

  • Department of Internal Medicine and Radboud Center of Infectious Diseases, Radboudumc, Radboud University, Nijmegen, The Netherlands.
  • Department of Internal Medicine and Infectious Diseases, Elizabeth-Tweesteden Ziekenhuis, Tilburg, The Netherlands.
  • Department of Internal Medicine, ErasmusMC, Erasmus University, Rotterdam, The Netherlands.
  • Department of Medical Microbiology and Infectious Diseases, ErasmusMC, Erasmus University, Rotterdam, The Netherlands.
  • Department of Internal Medicine and Infectious Diseases, OLVG, Amsterdam, The Netherlands.
  • Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

ORCID-Profile: Adriana Navas

Förderung

  • ViiV Healthcare
  • AIDS-Fonds

Zitieren

APA

Navas, A., Matzaraki, V., van Eekeren, L. E., Blaauw, M. J. T., Groenendijk, A. L., Vos, W. A. J. W., Jacobs-Cleophas, M., Dos Santos, J. C., van der Ven, A. J. A. M., Joosten, L. A. B., & Netea, M. G. (2025). Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV. Aging Cell. https://doi.org/10.1111/acel.14468

Vancouver

Navas A, Matzaraki V, van Eekeren LE, Blaauw MJT, Groenendijk AL, Vos WAJW, et al. Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV. Aging Cell. 2025. doi:10.1111/acel.14468

BibTeX
@article{Navas2025,
  author = {Navas, Adriana and Matzaraki, Vasiliki and van Eekeren, Louise E and Blaauw, Marc J T and Groenendijk, Albert L and Vos, Wilhelm A J W and Jacobs-Cleophas, Maartje and Dos Santos, Jéssica C and van der Ven, André J A M and Joosten, Leo A B and Netea, Mihai G},
  title = {Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV},
  journal = {Aging Cell},
  year = {2025},
  doi = {10.1111/acel.14468}
}
Kostenlos starten →